Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer (Q43047050)

12 November 2017

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer (English)

1 reference

12 November 2017

tick-borne encephalitis

1 reference

Zent O

1

1 reference

12 November 2017

Banzhoff A

2

1 reference

12 November 2017

Hilbert AK

3

1 reference

12 November 2017

Meriste S

4

1 reference

12 November 2017

Słuzewski W

5

1 reference

12 November 2017

Wittermann Ch

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

12 November 2017

1 reference

12 November 2017

21

1 reference

12 November 2017

25-26

1 reference

12 November 2017

3584-3592

1 reference

The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

[Tick-borne encephalitis in children (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Immediate allergic reactions after vaccinations--a post-marketing surveillance review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Laboratory findings in tick-borne encephalitis--correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Lower degree of fever at the initial febrile convulsion is associated with increased risk of subsequent convulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

Factors triggering the first febrile seizure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900421-3

1 reference

7 January 2021

10.1016/S0264-410X(03)00421-3

Identifiers

DOI

1 reference

12 November 2017

1 reference